Holen Sie sich die Stockscreener-App
2.208
4.15%
0.088
Handel nachbörslich:
2.11
-0.098
-4.44%
Schlusskurs vom Vortag:
$2.12
Offen:
$2.13
24-Stunden-Volumen:
28,738
Relative Volume:
0.46
Marktkapitalisierung:
$106.91M
Einnahmen:
$63.69M
Nettoeinkommen (Verlust:
$-44.82M
KGV:
-1.104
EPS:
-2
Netto-Cashflow:
$-30.56M
1W Leistung:
-0.99%
1M Leistung:
+0.36%
6M Leistung:
-4.00%
1J Leistung:
-2.73%
1-Tages-Spanne:
$2.0689
$2.23
1-Wochen-Bereich:
$2.0689
$2.32
52-Wochen-Spanne:
$1.35
$3.50
Mdxhealth Sa Stock (MDXH) Company Profile
Firmenname
Mdxhealth Sa
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MDXH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
2.208 | 106.91M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
427.76 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
202.50 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
542.71 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
120.66 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
164.65 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-31 | Eingeleitet | Lake Street | Buy |
| 2023-05-31 | Eingeleitet | TD Cowen | Outperform |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
Mdxhealth Sa Aktie (MDXH) Neueste Nachrichten
Citadel Advisors LLC Sells 40,324 Shares of MDxHealth SA (NASDAQ:MDXH) - Defense World
mdxhealth sa reschedules extraordinary general meeting for june 27 By Investing.com - Investing.com India
mdxhealth sa reschedules extraordinary general meeting for june 27 - Investing.com
MDxHealth Schedules Second EGM for Share Option Plan Approval - TipRanks
Northern Trust Corp Takes $1.03 Million Position in MDxHealth SA (NASDAQ:MDXH) - Defense World
MDxHealth (NASDAQ:MDXH) Upgraded to Hold at Wall Street Zen - Defense World
What is William Blair’s Forecast for MDxHealth Q3 Earnings? - Defense World
MDxHealth SA (NASDAQ:MDXH) Q1 2025 Earnings Call Transcript - Insider Monkey
MDxHealth Earnings Call: Growth Amid Financial Challenges - TipRanks
MDxHealth SA (MDXH) Reports Q1 Loss, Tops Revenue Estimates - MSN
MDxHealth SA (MDXH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational ... - Yahoo Finance
MDxHealth SA (MDXH) Q1 2025 Earnings Call Highlights: Strong Rev - GuruFocus
MDxHealth Reports Strong Q1 2025 Revenue Growth - TipRanks
MDxHealth ADR earnings missed by $0.01, revenue topped estimates - Investing.com India
MDxHealth SA reports results for the quarter ended March 31Earnings Summary - TradingView
MDxHealth Reports Q1 2025 Financial Results with Increased Revenue but Continued Losses - TipRanks
MDxHealth Reports Q1-2025 Results - The Manila Times
MDxHealth SA (MDXH) Q1 2025: Everything You Need to Know Ahead o - GuruFocus
MDxHealth SA (MDXH) Q1 2025: Everything You Need to Know Ahead of Earnings - Yahoo Finance
MDXHEALTH SA Earnings Preview: Recent $MDXH Insider Trading, Hedge Fund Activity, and More - Nasdaq
MDxHealth (MDXH) Projected to Post Quarterly Earnings on Wednesday - Defense World
MDxHealth Reports Strong Financial Turnaround in 2024 - TipRanks
Renaissance Technologies LLC Boosts Stake in MDxHealth SA (NASDAQ:MDXH) - Defense World
MDxHealth Schedules Key Shareholders’ Meetings for May 2025 - TipRanks
Global Molecular Diagnostics Market to Expand at a CAGR of ~9% by 2032 Due to the Rising Demand for Precision Medicine | DelveInsight - GlobeNewswire Inc.
Mdxhealth to Release First Quarter 2025 Financial Results on May 14 - The Manila Times
Mdxhealth to Release First Quarter 2025 Financial Results on May 14 | Nation/World | bdtonline.com - Bluefield Daily Telegraph
MDxHealth SA Announces Promising Research Results with New Liquid Biopsy Test in Development - marketscreener.com
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
Bleichroeder LP's Strategic Acquisition of MDxHealth SA Shares - GuruFocus
MDxHealth SA (NASDAQ:MDXH) Short Interest Up 133.8% in February - Defense World
Oppenheimer & Co. Inc. Has $47,000 Holdings in MDxHealth SA (NASDAQ:MDXH) - Defense World
MDxHealth CEO acquires company shares worth $80,000 By Investing.com - Investing.com Australia
MDxHealth stock hits 52-week low at $1.49 amid market challenges - Investing.com Canada
MDxHealth stock hits 52-week low at $1.49 amid market challenges By Investing.com - Investing.com South Africa
MDxHealth CEO acquires company shares worth $80,000 - Investing.com India
Down -15.22% in 4 Weeks, Here's Why You Should You Buy the Dip in MDxHealth SA (MDXH) - Yahoo Finance
Research Analysts Issue Forecasts for MDxHealth Q1 Earnings - Defense World
What is William Blair’s Forecast for MDxHealth Q1 Earnings? - Defense World
MDxHealth SA (MDXH) Reports Q4 Loss, Tops Revenue Estimates - MSN
MDxHealth SA (NASDAQ:MDXH) Q3 2024 Earnings Call Transcript - MSN
Mdxhealth S.A. Reports Strong Revenue Growth in Earnings Call - TipRanks
MDxHealth (NASDAQ:MDXH) Issues Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Q4 2024 Earnings Call Transcript - Insider Monkey
Mdxhealth fourth quarter revenue grows 28% to USD 24.7M - Medical Buyer
MDxHealth SA (MDXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Challenges - Yahoo Finance
MDxHealth ADR earnings beat by $0.05, revenue topped estimates - Investing.com South Africa
Finanzdaten der Mdxhealth Sa-Aktie (MDXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.52%
0.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):